ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    CD40 Signaling in Proximal Tubules Regulates Fibrosis in Both Hypertension and Chronic Allograft Rejection

    V. Bletsos, J. Breidenbach, S. Haller, S. Stepkowski.

    University of Toledo College of Medicine and Life Sciences, Toledo, OH.

    Background: We explored the role of CD40 signaling in kidney proximal tubule epithelial cells on renal interstitial fibrosis (IF) in two models: hypertension; and chronic…
  • 2018 American Transplant Congress

    Optimizing Outcomes with a Collaborative Approach after Kidney Transplant in Hepatitis C-Positive Recipients Receiving Hepatitis C-Positive Grafts

    A. Ray, R. Rubin, T. Ommert, R. Cross, C. Klein.

    Piedmont Transplant Institute, Piedmont Healthcare, Atlanta, GA.

    PURPOSE: To evaluate the multidisciplinary approach to HCV treatment in HCV+ kidney recipients receiving HCV+ grafts. METHODS: Single center review of treatment and outcomes in…
  • 2018 American Transplant Congress

    The First 9 Years of KPD through the National Kidney Registry: Characteristics of Donors and Recipients Compared to National Transplant Registries

    S. Flechner,1 A. Thomas,2 M. Ronin,3 J. Veale,4 D. Leeser,5 S. Kapur,6 J. Piepert,4 D. Segev,2 G. Hil,3 A. Waterman.4

    1Cleveland Clinic, Cleveland, OH; 2Johns Hopkins, Baltimore, MD; 3National Kidney Registry, Babylon, NY; 4UCLA, Los Angeles, CA; 5East Carolina, Greenville, NC; 6Cornell, New York, NY.

    Purpose: The NKR is a voluntary network of 75 transplant centers in 28 States in the USA focused on the facilitation of live donor kidney…
  • 2018 American Transplant Congress

    Intragraft Gene Expression Differentiates Polyomavirus Nephropathy from T-Cell Mediated Rejection

    B. Adam,1 S. Wagner,1 J. Bräsen,2 V. Bröcker,2 V. D'Agati,3 C. Drachenberg,4 E. Farkash,5 A. Farris,6 L. Geldenhuys,7 A. Magil,8 V. Nickeleit,9 P. Randhawa,10 H. Regele,11 M. Mengel.1

    1University of Alberta, Edmonton, Canada; 2Hannover Medical School, Hannover, Germany; 3Columbia University, New York; 4University of Maryland, College Park; 5University of Michigan, Ann Arbor; 6Emory University, Atlanta; 7Dalhousie University, Halifax, Canada; 8University of British Columbia, Vancouver, Canada; 9University of North Carolina, Chapel Hill; 10University of Pittsburgh, Pittsburgh; 11Medical University of Vienna, Vienna, Austria.

    Background: Improved immunosuppression protocols have reduced the incidence of T-cell mediated rejection (TCMR) but still carry a significant risk of BK polyomavirus nephropathy (BKVN). Despite…
  • 2018 American Transplant Congress

    Significant Alteration in Transplant Center Performance Assessment with Extended Patient Follow Up Time

    J. Schold, D. Goldfarb, S. Flechner, A. Wee, E. Poggio.

    Cleveland Clinic, Cleveland.

    IntroductionCurrent transplant center performance models focus on 1-year graft and patient survival as primary outcomes. This is despite that 2.5 year cohorts are used to…
  • 2018 American Transplant Congress

    Altered Function of Cytomegalovirus Specific T Cells in Transplant Recipients

    L. Higdon,1 J. Trofe-Clark,2 S. Liu,1 N. Saligrama,1 K. Margulies,2 M. Davis,1 J. Maltzman.1,3

    1Stanford U, Stanford, CA; 2U Pennsylvania, Philadelphia, PA; 3VA Palo Alto, Palo Alto, CA.

    Background: Cytomegalovirus (CMV) reactivation is associated with increased morbidity and mortality in transplant recipients. CMV establishes latency for the host's lifetime and frequently reactivates. Immunosuppression,…
  • 2018 American Transplant Congress

    Role of C1q-Binding Donor-Specific Anti-HLA Antibodies in Premature and Accelerated Kidney Allograft Interstitial Fibrosis

    K. Louis, D. Viglietti, O. Aubert, A. Loupy, C. Lefaucheur.

    Paris Translational Research Center for Organ Transplantation, Paris, France.

    The 2017 Banff meeting has focused on the importance of a precise diagnosis of IF/TA in kidney recipients by addressing specific etiological factors. Recent studies…
  • 2018 American Transplant Congress

    RNA Expression Profiling of Renal Allografts in the Cynomolgus Monkey Identifies Tolerance

    R. Smith,1 M. Matsunami,3 B. Adam,2 A. Rosales,1 T. Oura,3 A. Cosimi,3 T. Kawai,3 M. Mengel,2 R. Colvin.1

    1Pathology, Massachusetts General Hospital, Boston, MA; 2Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; 3Department of Surgery, Massachusetts General Hospital, Boston, MA.

    IntroductionTolerance induction is a long standing clinical goal. However, identification remains elusive. Here we profile intra-renal allograft RNA expression in a mixed chimerism renal allograft…
  • 2018 American Transplant Congress

    Rituximab Interference in B-Cell Crossmatch: A Problem Solved

    P. Malvezzi,1 O. Senoussi,2 T. Jouve,1 C. De Palma,2 L. Rostaing,1 B. Bardy,2 D. Masson.2

    1Service de Néphrologie, Dialyse, Aphérèses et Transplantation, CHU Grenoble Alpes, Grenoble, France; 2Laboratoire d'Histocompatibilité, EFS Rhone Alpes, Grenoble, France.

    Background: Rituximab is commonly prescribed in ABO- or HLA-incompatible kidney transplantation. When used before transplant it interferes with B lymphocyte complement-dependent crossmatch (CDC CM) or…
  • 2018 American Transplant Congress

    A 3C Approach Drives Epigenetic Fixation of Foxp3 Expression and Stabilizes Treg Cell Lineage and Therapeutic Function

    X. Xiao, X. Zhang, J. Li, S. Chen, P. Lan, Y. Dou, W. Chen, X. Li.

    Immunobiology & Transplant Research Center, Houston Methodist Hospital, Houston, TX.

    The instability of the regulatory T (Treg) cell lineage precludes their therapeutic potential in transplantation and autoimmune diseases. Herein, we invented a novel approach to…
  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences